CRSP Financing Cash Flow
Crispr Therapeutics Ag · Financing Cash Flow
CRSP Financing Cash Flow
Latest reported$1.01Bperiod ending
CRSP TTM Cash from Financing ($96.73M → $1.01B)
TTM financing cash flow
High-resolution chart · PNG
CRSP financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 1,012,268,000 | |
| 1,007,346,000 | |
| 426,026,000 | |
| 326,488,000 | |
| 39,362,000 | |
| 36,638,000 | |
| 331,984,000 | |
| 354,047,000 | |
| 345,963,000 | |
| 363,194,000 | |
| 62,664,000 | |
| 26,203,000 | |
| 39,759,000 | |
| 33,347,000 | |
| 38,592,000 | |
| 42,413,000 | |
| 37,513,000 | |
| 35,603,000 | |
| 250,945,000 | |
| 657,273,000 | |
| 1,159,949,000 | |
| 1,241,011,000 | |
| 1,016,152,000 | |
| 908,243,000 | |
| 466,240,000 | |
| 406,389,000 | |
| 430,983,000 | |
| 124,996,000 | |
| 242,334,000 | |
| 216,409,000 | |
| 315,934,000 | |
| 318,487,000 | |
| 130,873,000 | |
| 127,839,000 | |
| 2,608,000 | |
| 93,090,000 | |
| 88,010,000 | |
| 148,240,000 | |
| 183,220,000 | |
| 129,936,000 | |
| 134,407,000 | |
| 126,440,000 | |
| 96,733,000 |